Inogen Valuation
| INGN Stock | USD 5.95 0.05 0.83% |
At this time, the firm appears to be undervalued. Inogen Inc retains a regular Real Value of $7.79 per share. The prevalent price of the firm is $5.95. Our model calculates the value of Inogen Inc from evaluating the firm fundamentals such as Return On Equity of -0.13, current valuation of 53 M, and Return On Asset of -0.0621 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Inogen's valuation include:
Price Book 0.8124 | Enterprise Value | Enterprise Value Ebitda (17.60) | Price Sales 0.4694 | Enterprise Value Revenue 0.159 |
Undervalued
Today
Please note that Inogen's price fluctuation is somewhat reliable at this time. Calculation of the real value of Inogen Inc is based on 3 months time horizon. Increasing Inogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inogen Stock. However, Inogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.95 | Real 7.79 | Target 13.0 | Hype 5.88 | Naive 5.9 |
The intrinsic value of Inogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Inogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Inogen Inc helps investors to forecast how Inogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inogen more accurately as focusing exclusively on Inogen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Inogen's intrinsic value based on its ongoing forecasts of Inogen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Inogen's closest peers.
Inogen Cash |
|
Inogen Total Value Analysis
Inogen Inc is currently forecasted to have valuation of 53 M with market capitalization of 162.89 M, debt of 19.41 M, and cash on hands of 223.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Inogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
53 M | 162.89 M | 19.41 M | 223.62 M |
Inogen Investor Information
About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inogen Inc recorded a loss per share of 1.0. The entity had not issued any dividends in recent years. Based on the analysis of Inogen's profitability, liquidity, and operating efficiency, Inogen Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Inogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inogen has an asset utilization ratio of 113.34 percent. This suggests that the Company is making $1.13 for each dollar of assets. An increasing asset utilization means that Inogen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Inogen Profitability Analysis
Considering Inogen's profitability and operating efficiency indicators, Inogen Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Inogen's ability to earn profits and add value for shareholders.Net Loss | First Reported 2012-09-30 | Previous Quarter -4.2 M | Current Value -5.3 M | Quarterly Volatility 13.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.52 | 0.53 |
|
|
For Inogen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Inogen Inc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Inogen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Inogen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Inogen over time as well as its relative position and ranking within its peers.
Inogen Earnings per Share Projection vs Actual
The next projected EPS of Inogen is estimated to be -0.225 with future projections ranging from a low of -0.25 to a high of -0.2. Inogen's most recent 12-month trailing earnings per share (EPS TTM) is at -1.0. Please be aware that the consensus of earnings estimates for Inogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Inogen Earnings Estimation Breakdown
The calculation of Inogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Inogen is estimated to be -0.225 with the future projection ranging from a low of -0.25 to a high of -0.2. Please be aware that this consensus of annual earnings estimates for Inogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.25 Lowest | Expected EPS | -0.2 Highest |
Inogen Earnings Projection Consensus
Suppose the current estimates of Inogen's value are higher than the current market price of the Inogen stock. In this case, investors may conclude that Inogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Inogen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 2 | 30.82% | 0.0 | -0.225 | -1.0 |
Inogen Ownership Allocation
Inogen Inc has a total of 27.15 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Inogen Profitability Analysis
The company reported the previous year's revenue of 335.7 M. Net Loss for the year was (35.89 M) with profit before overhead, payroll, taxes, and interest of 155.32 M.About Inogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Inogen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Inogen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Inogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Inogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inogen. We calculate exposure to Inogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inogen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 178 M | 120.1 M | |
| Pretax Profit Margin | (0.11) | (0.12) | |
| Operating Profit Margin | (0.15) | (0.14) | |
| Net Loss | (0.11) | (0.12) | |
| Gross Profit Margin | 0.53 | 0.52 |
Inogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 23.7 M | |
| Quarterly Earnings Growth Y O Y | 0.873 |
Inogen Current Valuation Indicators
Inogen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Inogen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Inogen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Inogen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Inogen's worth.When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Health Care Equipment & Supplies sector continue expanding? Could Inogen diversify its offerings? Factors like these will boost the valuation of Inogen. Market participants price Inogen higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.873 | Earnings Share (1.00) | Revenue Per Share | Quarterly Revenue Growth 0.04 | Return On Assets |
Investors evaluate Inogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Inogen's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inogen's market price signifies the transaction level at which participants voluntarily complete trades.